Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients

International Journal of Antimicrobial Agents

Volumn 28, Issue 1, 2006, Pages 6-13

  Kim, Jung Mogg ^a   Kim, Joo Sung ^b   Kim, Nayoung ^b   Kim, Sang Gyun ^b   Jung, Hyun Chae ^b   Song, In Sung ^b  

^a Hanyang University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Antimicrobial resistance; MIC; Multidrug resistance

Indexed keywords

ALANINE; AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN BINDING PROTEIN 1A; PROTEIN; SERINE; TETRACYCLINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL MUTATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; KOREA; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DNA PRIMERS; DRUG RESISTANCE, MICROBIAL; HELICOBACTER PYLORI; HUMANS; KOREA; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION;

EID: 33745215810     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.02.015     Document Type: Article

References (35)

1. Dunn B.E., Cohen H., and Blaser M.J. Helicobacter pylori. Clin Microbiol Rev 10 (1997) 720-741
2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272 (1994) 65-69
3. Graham D.Y., Lew G.M., Klein P.D., et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med 116 (1992) 705-708
4. Hentschel E., Brandstatter G., Dragosics B., et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328 (1993) 308-312
5. Lind T., Megraud F., Unge P., et al. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 116 (1999) 248-253
6. Adamek R.J., Suerbaum S., Pfaffenbach B., and Opferkuch W. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin-influence on treatment outcome. Am J Gastroenterol 93 (1998) 386-389
7. Graham D.Y. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 115 (1998) 1272-1277
8. Huang J.Q., and Hunt R.H. Treatment after failure: the problem of non-responders. Gut 45 Suppl. 1 (1999) I40-I44
9. Kim J.M., Kim J.S., Jung H.C., Kim N., Kim Y.J., and Song I.S. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob Agents Chemother 48 (2004) 4843-4847
10. Kim J.M., Kim J.S., Kim N., Jung H.C., and Song I.S. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother 56 (2005) 965-967
11. Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 115 (1998) 1278-1282
12. Glupczynski Y., Megraud F., Lopez-Brea M., and Anderson L.P. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 20 (2001) 820-823
13. Cabrita J., Oleastro M., Matos R., et al. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999). J Antimicrob Chemother 46 (2000) 1029-1031
14. Heep M., Kist M., Strobel S., Beck D., and Lehn N. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis 19 (2000) 538-541
15. Pilotto A., Franceschi M., Rassu M., et al. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study. Dig Liver Dis 32 (2000) 667-672
16. Samra Z., Shmuely H., Niv Y., et al. Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J Antimicrob Chemother 49 (2002) 1023-1026
17. Tankovic J., Lamarque D., Lascols C., Soussy C.J., and Delchier J.C. Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. Aliment Pharmacol Ther 15 (2001) 707-713
18. Cheon J.H., Kim N., Lee D.H., et al. Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failures for Helicobacter pylori infection. Korean J Gastroenterol 45 (2005) 111-117
19. Kim J.M., Kim J.S., Jung H.C., Song I.S., and Kim C.Y. Virulence factors of Helicobacter pylori in Korean isolates do not influence proinflammatory cytokine gene expression and apoptosis in human gastric epithelial cells, nor do these factors influence the clinical outcome. J Gastroenterol 35 (2000) 898-906
20. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelfth Informational Supplement M100-S12 (2002), NCCLS, Wayne, PA
21. Paul R., Postius S., Melchers K., and Schafer K.P. Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin. Antimicrob Agents Chemother 45 (2001) 962-965
22. Kwon D.H., Dore M.P., Kim J.J., et al. High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother 47 (2003) 2169-2178
23. Boyanova L., Mentis A., Gubina M., et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect 8 (2002) 388-396
24. Toracchio S., and Marzio L. Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002. Dig Liver Dis 35 (2003) 541-545
25. Megraud F., Lehn N., Lind T., et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 43 (1999) 2747-2752
26. Ivashkin V.T., Lapina T.L., Bondarenko O.Y., et al. Azithromycin in a triple therapy for H. pylori eradication in active duodenal ulcer. World J Gastroenterol 8 (2002) 879-882
27. Xia H.H., Yu Wong B.C., Talley N.J., and Lam S.K. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opin Pharmacother 3 (2002) 1301-1311
28. DeLoney C.R., and Schiller N.L. Characterization of an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob Agents Chemother 44 (2000) 3368-3373
29. Okamoto T., Yoshiyama H., Nakazawa T., et al. A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori. J Antimicrob Chemother 50 (2002) 849-856
30. Gerrits M.M., Schuijffel D., van Zwet A.A., Kuipers E.J., Vandenbroucke-Grauls C.M., and Kusters J.G. Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori. Antimicrob Agents Chemother 46 (2002) 2229-2233
31. Lee Y.C., Lee S.Y., Pyo J.H., Kwon D.H., Rhee J.C., and Kim J.J. Isogenic variation of Helicobacter pylori strain resulting in heteroresistant antibacterial phenotypes in a single host in vivo. Helicobacter 10 (2005) 240-248
32. Kim J.J., Kim J.G., and Kwon D.H. Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 8 (2003) 202-206
33. Rimbara E., Noguchi N., Tanabe M., Kawai T., Matsumoto Y., and Sasatsu M. Susceptibilities to clarithromycin, amoxicillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001. Clin Microbiol Infect 11 (2005) 307-311
34. Kato S., Fujimura S., Udagawa H., et al. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol 40 (2002) 649-653
35. Glupczynski Y., and Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 85 (1990) 1545-1551